Xtl Biopharmaceuticals (XTLB) Exchange Rate Effect (2011 - 2016)
Xtl Biopharmaceuticals (XTLB) posted quarterly Exchange Rate Effect of $3000.0 for Q2 2016, down 91.67% year-on-year from $36000.0 in Q3 2015, and up 200.0% on a QoQ basis from -$3000.0 in Q4 2015.
Xtl Biopharmaceuticals (XTLB) Exchange Rate Effect (2011 - 2016) Analysis & Trends
Xtl Biopharmaceuticals (XTLB) has reported Exchange Rate Effect for 6 consecutive years, with $3000.0 the latest figure, recorded in Q2 2016.
- Quarterly Exchange Rate Effect fell 91.67% year-over-year to $3000.0 in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $17000.0 (down 34.62% YoY) and the FY2025 annual result came in at -$35000.0, down 133.33% from the prior year.
- Exchange Rate Effect improved to $3000.0 in Q2 2016 per XTLB's latest filing, from -$3000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for XTLB reached as high as $44000.0 in Q4 2012 and fell as low as -$58000.0 in Q2 2012.
- A 5-year average of $2812.5 and a median of $500.0 in 2013 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2012 — Exchange Rate Effect jumped 2300.0% — and 2014, when it sank 1850.0%.
- Year by year, Exchange Rate Effect stood at $44000.0 in 2012, then retreated by 18.18% to $36000.0 in 2013, then plunged by 77.78% to $8000.0 in 2014, then tumbled by 137.5% to -$3000.0 in 2015, then surged by 200.0% to $3000.0 in 2016.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $3000.0, -$3000.0, and -$19000.0 for Q2 2016, Q4 2015, and Q3 2015 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | Xtl Biopharmaceuticals | 2.58 Bn | 2.58 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 3,000.00 |
| Jun 30, 2016 | 3,000.00 |
| Dec 31, 2015 | -3,000.00 |
| Dec 31, 2015 | -3,000.00 |
| Sep 30, 2015 | -19,000.00 |
| Sep 30, 2015 | -19,000.00 |
| Jun 30, 2015 | 36,000.00 |
| Jun 30, 2015 | 36,000.00 |
| Dec 31, 2014 | 8,000.00 |
| Dec 31, 2014 | 8,000.00 |
| Sep 30, 2014 | -39,000.00 |
| Sep 30, 2014 | -39,000.00 |
| Jun 30, 2014 | 21,000.00 |
| Jun 30, 2014 | 21,000.00 |
| Mar 31, 2014 | -4,000.00 |
| Mar 31, 2014 | -4,000.00 |
| Dec 31, 2013 | 36,000.00 |
| Dec 31, 2013 | 36,000.00 |
| Sep 30, 2013 | -2,000.00 |
| Sep 30, 2013 | -2,000.00 |